Diamyd Medical

Diamyd Medical is a Swedish biotechnology company focused on the development of pharmaceutical therapies for the treatment and prevention of type 1 diabetes. Its primary clinical asset is the therapeutic antigen-based vaccine Diamyd, which is currently undergoing late-stage clinical trials.